News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
467,732 Results
Type
Article (32374)
Company Profile (63)
Press Release (435295)
Section
Business (132358)
Career Advice (2501)
Deals (26509)
Drug Delivery (81)
Drug Development (62995)
Employer Resources (141)
FDA (11400)
Job Trends (10753)
News (236200)
Policy (22937)
Tag
Academia (1898)
Alliances (33542)
Alzheimer's disease (1119)
Approvals (11365)
Artificial intelligence (141)
Bankruptcy (231)
Best Places to Work (8662)
Breast cancer (177)
Cancer (1294)
Cardiovascular disease (106)
Career advice (2059)
CAR-T (87)
Cell therapy (265)
Clinical research (50849)
Collaboration (486)
Compensation (111)
COVID-19 (2188)
C-suite (80)
Data (1307)
Diabetes (154)
Diagnostics (4954)
Earnings (58955)
Employer resources (123)
Events (71643)
Executive appointments (289)
FDA (12025)
Funding (367)
Gene therapy (187)
GLP-1 (558)
Government (3491)
Healthcare (13017)
Infectious disease (2273)
Inflammatory bowel disease (94)
Interviews (477)
IPO (13465)
Job creations (2450)
Job search strategy (1734)
Layoffs (313)
Legal (4577)
Lung cancer (190)
Lymphoma (92)
Manufacturing (187)
Medical device (9508)
Medtech (9510)
Mergers & acquisitions (13307)
Metabolic disorders (434)
Neuroscience (1435)
NextGen: Class of 2025 (4121)
Non-profit (2681)
Northern California (1483)
Obesity (245)
Opinion (222)
Patents (109)
People (32087)
Phase I (15627)
Phase II (22711)
Phase III (17575)
Pipeline (584)
Postmarket research (1645)
Preclinical (5876)
Radiopharmaceuticals (190)
Rare diseases (259)
Real estate (3643)
Regulatory (16140)
Research institute (1717)
Resumes & cover letters (426)
Southern California (1281)
Startups (2264)
United States (12591)
Vaccines (507)
Weight loss (179)
Date
Today (105)
Last 7 days (699)
Last 30 days (1680)
Last 365 days (28308)
2025 (1029)
2024 (28471)
2023 (32153)
2022 (40767)
2021 (42822)
2020 (40818)
2019 (32112)
2018 (24262)
2017 (24740)
2016 (22531)
2015 (26581)
2014 (19035)
2013 (22338)
2012 (15802)
2011 (16368)
2010 (14474)
Location
Africa (667)
Asia (28463)
Australia (4767)
California (3280)
Canada (1257)
China (286)
Colorado (141)
Connecticut (149)
Europe (63617)
Florida (469)
Georgia (107)
Illinois (270)
Indiana (195)
Japan (86)
Maryland (535)
Massachusetts (2419)
Michigan (141)
Minnesota (207)
New Jersey (976)
New York (974)
North Carolina (552)
Northern California (1483)
Ohio (103)
Pennsylvania (747)
South America (877)
Southern California (1281)
Texas (472)
Utah (100)
Washington State (362)
467,732 Results for "biom up".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Psyence Biomed Announces $2.0 Million Private Placement
December 23, 2024
·
6 min read
Press Releases
Anaconda Biomed Appoints Trent Reutiman New CEO
January 7, 2025
·
3 min read
Business
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its first quarter 2024 financial results and provided a business update.
May 13, 2024
·
13 min read
Press Releases
Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update
November 13, 2024
·
12 min read
Press Releases
Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial
December 17, 2024
·
6 min read
Drug Development
BioMed X Start Collaboration in Autoimmunity Research with Servier
The new research team at the BioMed X Institute in Heidelberg will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.
June 26, 2024
·
3 min read
Press Releases
Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update
October 22, 2024
·
9 min read
Press Releases
Harbour BioMed Announces License Agreement with Windward Bio for HBM9378/SKB378, an Anti-TSLP Fully Human Antibody for Immunological Diseases
January 10, 2025
·
4 min read
Business
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its full year 2023 financial results and provided a fourth quarter business update.
March 27, 2024
·
13 min read
Press Releases
Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
December 20, 2024
·
4 min read
1 of 46,774
Next
